APA (7th ed.) Citation

LX, L., BY, W., L, J., Y, W., ZY, Y., C, L., . . . XF, L. (2026). Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathway. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01852-3

Chicago Style (17th ed.) Citation

LX, Li, et al. "Clemastine Alleviates Cognitive Dysfunction After SAH by Targeting Neuronal CNTN1 to Regulate the ADA-adenosine Pathway." Acta Pharmacologica Sinica 2026. https://doi.org/10.1038/s41401-026-01852-3.

MLA (9th ed.) Citation

LX, Li, et al. "Clemastine Alleviates Cognitive Dysfunction After SAH by Targeting Neuronal CNTN1 to Regulate the ADA-adenosine Pathway." Acta Pharmacologica Sinica, 2026, https://doi.org/10.1038/s41401-026-01852-3.